Sanofi
Why Robinhood?
You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!About SNY
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines.
SNY Key Statistics
SNY News
Sanofi SA ( (SNY) ) has released its Q1 earnings. Here is a breakdown of the information Sanofi SA presented to its investors. Sanofi SA, a leading global heal...
Sanofi ( (SNY) ) has provided an announcement. In April 2025, Sanofi reported a strong performance for the first quarter, with a 9.7% increase in sales at cons...
Sanofi SA SNY reported Thursday a first-quarter 2025 business operating income of 2.9 billion euros ($3.06 billion), up 20.1% year over year and 18.7% in consta...
Analyst ratings
84%
of 25 ratingsMore SNY News
Shares of Sanofi (NASDAQ:SNY) and Roche (OTCQX:RHHBY) were flat in European trading on Thursday after the EU pharma giants reaffirmed their full-year forecasts...
Sanofi (SNYNF – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Graham Parry from Bank of America Securit...
Innate Pharma (IPHA) announced a EUR 15M capital increase subscribed by Sanofi (SNY). As announced on April 23 and given the satisfactory market conditions, San...
Innate Pharma SA ( (FR:IPH) ) just unveiled an announcement. Innate Pharma announced on April 23, 2025, that it will regain its rights to the CD123 targeting A...
Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) announced that the U.S. Food and Drug Administration has approved Dupixent for the treatment of adults and ado...